Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | Asthma 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 [1] 97 💬
|
2 | Asthma 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 [1] 85 💬
|
3 | Asthma 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 [2] 85, 97 💬
|
4 | Cytokine-cytokine receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 [1] 97 💬
|
5 | Cytokine-cytokine receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 [1] 85 💬
|
6 | Cytokine-cytokine receptor interaction 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 [2] 85, 97 💬
|
7 | Fc epsilon RI signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 [1] 97 💬
|
8 | Fc epsilon RI signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 [1] 85 💬
|
9 | Fc epsilon RI signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 [2] 85, 97 💬
|
10 | IL-17 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 [1] 97 💬
|
11 | IL-17 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 [1] 85 💬
|
12 | IL-17 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 [2] 85, 97 💬
|
13 | Inflammatory bowel disease 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 [1] 97 💬
|
14 | Inflammatory bowel disease 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 [1] 85 💬
|
15 | Inflammatory bowel disease 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 [2] 85, 97 💬
|
16 | JAK-STAT signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 [1] 97 💬
|
17 | JAK-STAT signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 [1] 85 💬
|
18 | JAK-STAT signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 [2] 85, 97 💬
|
19 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 [1] 97 💬
|
20 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 [1] 85 💬
|
21 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 [2] 85, 97 💬
|
22 | Th1 and Th2 cell differentiation 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Anrukinzumab Anrukinzumab 💬
| Anrukinzumab | 097 [1] 97 💬
|
23 | Th1 and Th2 cell differentiation 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Lebrikizumab Lebrikizumab 💬
| Lebrikizumab | 085 [1] 85 💬
|
24 | Th1 and Th2 cell differentiation 💬 1 gene, 3 drugs (DrugBank) and 2 diseases |
IL13 [1] IL13 💬
|
Tralokinumab Tralokinumab 💬
| Tralokinumab | 085 [2] 85, 97 💬
|